Iterum Therapeutics plc Gains 60.68%
Fri, Oct 25, 2024 at 07:42 PM
Iterum Therapeutics plc (ITRM:NASDAQ) jumped higher at $1.88, a gain of 60.7%. On Fri, Oct 25, 2024, ITRM:NASDAQ touched a New 2-Week High of $1.88. The stock got featured on our News Catalysts scanner on Fri, Oct 25, 2024 at 01:52 PM in the 'BIOTECH' category. From Fri, Oct 11, 2024, the stock recorded 80.00% Up Days and 45.45% Green Days
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Smart for Life Inc. (SMFL:NASDAQ), 172.09%
- Upexi Inc Com (UPXI:NASDAQ), 170%
- ARB IOT Group Limited (ARBB:NASDAQ), 107.3%
- NWTN Inc. (NWTN:NASDAQ), 62.44%
- Iterum Therapeutics plc (ITRM:NASDAQ), 60.68%
- BM Technologies Inc. (BMTX:NYSEMKT), 47.21%
- Fitell Corporation (FTEL:NASDAQ), 44.39%
- SRAX, Inc. (SRAX:NASDAQ), 40%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 36.86%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 31.01%